Company intelligence

CDT Equity

BiotechActive

Is this your company? Get featured or correct your listing →

We're still building this profile — here is what Pulse has covered.

Latest Pulse

  1. What 2026's Record IPO Pipeline Actually Shows2026's IPO market is running roughly flat with 2025's pace by deal count, but the pipeline is increasingly bifurcated between mega-cap AI listings and a steady drip of microcap S-1 filings with little institutional demand.→
  2. Two Microcaps File S-1s: Biotech Rebrand, OTC RollupCDT Equity, a Nasdaq-listed biopharma formerly known as Conduit Pharmaceuticals, and Securetech Innovations, an OTC-listed technology holding company, both filed new S-1 registrations the same day.→

Coverage Timeline

newest first
  1. Sep 8, 2026IPOTwo Microcaps File S-1s: Biotech Rebrand, OTC Rollup→

All Coverage

IPO

Two Microcaps File S-1s: Biotech Rebrand, OTC Rollup

Illustration for: Two Microcaps File S-1s: Biotech Rebrand, OTC Rollup
IPO

Two Microcaps File S-1s: Biotech Rebrand, OTC Rollup

CDT Equity, a Nasdaq-listed biopharma formerly known as Conduit Pharmaceuticals, and Securetech Innovations, an OTC-listed technology holding company, both filed new S-1 registrations the same day.

DEEP DIVE

Related Companies

Same sector
Scribe TherapeuticsIambic TherapeuticsAttovia TherapeuticsApnimedEli LillyRetension Pharmaceuticals